Natalia Rosso
Natalia Rosso
Fondazione Italiana Fegato - ONLUS
Email verificata su fegato.it - Home page
TitoloCitata daAnno
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
NC Chavez-Tapia, N Rosso, C Tiribelli
BMC gastroenterology 12 (1), 20, 2012
1042012
Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance
V Di Maso, C Avellini, LS Crocè, N Rosso, F Quadrifoglio, L Cesaratto, ...
Molecular medicine 13 (1-2), 89-96, 2007
942007
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation …
G Grassi, B Scaggiante, R Farra, B Dapas, F Agostini, D Baiz, N Rosso, ...
Biochimie 89 (12), 1544-1552, 2007
822007
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
AR Araújo, N Rosso, G Bedogni, C Tiribelli, S Bellentani
Liver International 38, 47-51, 2018
772018
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness
D Spano, R Russo, V Di Maso, N Rosso, LM Terracciano, M Roncalli, ...
Molecular medicine 16 (3), 102, 2010
742010
Translational approaches: from fatty liver to non-alcoholic steatohepatitis
N Rosso, NC Chavez-Tapia, C Tiribelli, S Bellentani
World journal of gastroenterology: WJG 20 (27), 9038, 2014
562014
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
CHC Sukowati, N Rosso, D Pascut, B Anfuso, G Torre, P Francalanci, ...
BMC gastroenterology 12 (1), 160, 2012
442012
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma
CHC Sukowati, N Rosso, LS Crocè, C Tiribelli
World journal of hepatology 2 (3), 114, 2010
412010
In vitro models for the study of non-alcoholic fatty liver disease
N C Chavez-Tapia, N Rosso, C Tiribelli
Current medicinal chemistry 18 (7), 1079-1084, 2011
382011
Effects of E2F1–cyclin E1–E2 circuit down regulation in hepatocellular carcinoma cells
R Farra, B Dapas, G Pozzato, B Scaggiante, F Agostini, C Zennaro, ...
Digestive and Liver Disease 43 (12), 1006-1014, 2011
342011
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation
PJ Giraudi, VJB Becerra, V Marin, NC Chavez-Tapia, C Tiribelli, N Rosso
Experimental and molecular pathology 98 (1), 85-92, 2015
312015
The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH
VJ Barbero-Becerra, PJ Giraudi, NC Chavez-Tapia, M Uribe, C Tiribelli, ...
Toxicology in Vitro 29 (7), 1753-1758, 2015
292015
Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis
M Barone, D Spano, M D’Apolito, M Centra, C Lasalandra, M Capasso, ...
Molecular Medicine 12 (4-6), 115-123, 2006
282006
Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles
S Zampieri, M Filocamo, E Buratti, M Stroppiano, K Vlahovicek, N Rosso, ...
Neurogenetics 10 (1), 49, 2009
232009
Alterations in the cell cycle in the cerebellum of hyperbilirubinemic Gunn rat: a possible link with apoptosis?
MC Robert, G Furlan, N Rosso, SE Gambaro, F Apitsionak, E Vianello, ...
PLoS One 8 (11), e79073, 2013
192013
An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
V Marin, N Rosso, M Dal Ben, A Raseni, M Boschelle, C Degrassi, ...
PLoS One 11 (7), e0158817, 2016
182016
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
CM Chackelevicius, SE Gambaro, C Tiribelli, N Rosso
World journal of gastroenterology 22 (41), 9096, 2016
162016
Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients
V Marin, K Poulsen, G Odena, MR McMullen, J Altamirano, P Sancho-Bru, ...
Journal of hepatology 67 (5), 1018-1025, 2017
142017
The pros and the cons for the use of silybin-rich oral formulations in treatment of liver damage (NAFLD in particular)
N Rosso, V Marin, A Giordani, S Persiani, F Sala, L Cavicchioli, ...
Current medicinal chemistry 22 (25), 2954-2971, 2015
142015
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes
NC Chávez-Tapia, N Rosso, M Uribe, R Bojalil, C Tiribelli
Annals of hepatology 13 (1), 113-120, 2014
142014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20